Are generic and disease-specific health related quality of life correlated? The case of chronic lung disease due to sulfur mustard

Journal of Research in Medical Sciences

Volumn 14, Issue 5, 2009, Pages 285-290

  Assari, Shervin ^a,b   Lankarani, Maryam Moghani ^a,b   Montazeri, Ali ^c   Soroush, Mohammad Reza ^c   Mousavi, Batol ^c  

^a Medicine and Health Promotion Institute   (Iran)

^b Scientific Writing Network   (Iran)

^c JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

Author keywords

Chronic lung disease; Disease specific health related quality of life; Generic health related quality of life; Health related quality of life; Sulfur mustard

Indexed keywords

MUSTARD GAS;

ADULT; ARTICLE; CHRONIC LUNG DISEASE; CORRELATIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; ST GEORGE RESPIRATORY QUESTIONNAIRE;

EID: 70449725126     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003;45(11):1136-1143 (Pubitemid 37420858)
2. Emad A, Rezaian GhR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 1997;112(3):734-738 (Pubitemid 27410711)
3. Ghanei M, Mokhtari M, Mohammad MM, Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 2004;52(2):164-169 (Pubitemid 39361117)
4. Thomason JW, Rice TW, Milstone AP. Bronchiolitis obliterans in a survivor of a chemical weapons attack. JAMA 2003;290(5):598-599 (Pubitemid 37430478)
5. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 2007;19(5-8):451-456 (Pubitemid 46364767)
6. McSweeny AJ, Grant I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982;142(3):473-478 (Pubitemid 12190735)
7. Jones PW, Baveystock CM, Littlejohns P. Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. Am Rev Respir Dis 1989;140(6):1538-1543 (Pubitemid 20041030)
8. Curtis JR, Deyo RA, Hudson LD. Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994;49(2):162-170
9. Leidy NK. Functional performance in people with chronic obstructive pulmonary disease. Image J Nurs Sch 1995;27(1):23-34.
10. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27(3 Suppl):S217-32.
11. Malý M, Vondra V. Generic versus disease-specific instruments in quality-of-life assessment of chronic obstructive pulmonary disease. Methods Inf Med 2006;45(2):211-215 (Pubitemid 44047767)
12. Thomas K, Ruby J, Peter JV, Cherian AM. Comparison of disease-specific and a generic quality of life measure in patients with bronchial asthma. Natl Med J India 1995;8(6):258-260
13. Alonso J, Prieto L, Ferrer M, Vilagut G, Broquetas JM, Roca J, et al. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of Life in COPD Study Group. J Clin Epidemiol 1998;51(11):1087-1094 (Pubitemid 28527164)
14. Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006;130(4):1117-1128
15. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996;51(1):44-47 (Pubitemid 26048725)
16. Ketelaars CA, Schlösser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, Wouters EF. Determinants of healthrelated quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996;51(1):39-43. (Pubitemid 26048724)
17. Breslin E, van der Schans C, Breukink S, Meek P, Mercer K, Volz W, et al. Perception of fatigue and quality of life in patients with COPD. Chest 1998;114(4):958-964 (Pubitemid 28495886)
18. Alemayehu B, Aubert RE, Feifer RA, Paul LD. Comparative analysis of two quality-of-life instruments for patients with chronic obstructive pulmonary disease. Value Health 2002;5(5):437-442
19. Aslani J, Mirzamani SM, AzizAbadi-Farahani M, Moghani Lankarani M, Assari S. Health-related quality of life in chronic obstructive pulmonary disease: are disease-specific and generic quality of life measures correlated? Tanaffos 2008;7(2):28-35. (Persian)
20. Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med 2006;119(10 Suppl 1):32-37
21. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005;14(3):875-882 (Pubitemid 40576872)
22. Ware JE, Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998;51(11):903-912
23. Ware JE, Kosinski M, Keller SK. SF-36 physical and mental health summary scales. A user's manual. Boston: The Health Institute, New England Medical Center; 1994.
24. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31, 33-37
25. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145(6):1321-1327
26. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001;56(11):880-887 (Pubitemid 32999838)
27. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002;19(3):398-404.
28. Fallah Tafti S, Marashian M, Cheraghvandi A, Emami H. Investigation of validity and reliability of Persian version of the "St George respiratory questionnaire". Pejuhandeh 2007;12(1):43-50. (Persian)
29. Shohrati M, Aslani J, Eshraghi M, Alaedini F, Ghanei M. Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test. Respir Med 2008;102(3):443-448 (Pubitemid 351179975)
30. Ghanei M, Shohrati M, Harandi AA, Eshraghi M, Aslani J, Alaeddini F, et al. Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhal Toxicol 2007;19(10):889-894 (Pubitemid 47237745)
31. Attaran D, Khajedaloui M, Jafarzadeh R, Mazloomi M. Health-related quality of life in patients with chemical warfare- induced chronic obstructive pulmonary disease. Arch Iran Med 2006;9(4):359-363 (Pubitemid 44803579)
32. Tavallaie SA, Assari Sh, Habibi M, Aziz Abadi Farahani M, Panahi Y, Alaeddini F, et al. Health related quality of life in subjects with chronic bronchiolitis obliterans due to chemical warfare agents. Military Medicine 2005:7(4);313-20. (Persian)
33. Jones PW. Quality of life measurement for patients with diseases of the airways. Thorax 1991;46(9):676-682
34. Katsura H, Yamada K, Kida K. Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med 2005;99(5):624-630 (Pubitemid 40468511)
35. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999;116(5):1175-1182 (Pubitemid 29535966)
36. Chen H, Eisner MD, Katz PP, Yelin EH, Blanc PD. Measuring disease-specific quality of life in obstructive airway disease: validation of a modified version of the airways questionnaire 20. Chest 2006;129(6):1644-1652 (Pubitemid 43894998)
37. Engström CP, Persson LO, Larsson S, Sullivan M. Health related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J 2001;18(1):69-76. (Pubitemid 32717433)
38. Ståhl E, Lindberg A, Jansson SA, Rönmark E, Svensson K, Andersson F, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 2005;3:56. (Pubitemid 41529215)
39. Kalpaklioglu AF, Kara T, Kurtipek E, Kocyigit P, Ekici A, Ekici M. Evaluation and impact of chronic cough: comparison of specific vs. generic quality-of-life questionnaires. Ann Allergy Asthma Immunol 2005;94(5):581-585 (Pubitemid 40712783)
40. Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, Oosting AJ, de Monchy JGR, Bruijnzeel-Koomen CAFM, et al. Comparison of a generic and a rhinitis-specific quality-of life (QOL) instrument in patients with house dust mite allergy: relationship between the SF-36 and Rhinitis QOL Questionnaire. Clin Exp Allergy 2004;34(11):1673-1677 (Pubitemid 39551518)
41. Leong KP, Yeak SC, Saurajen AS, Mok PK, Earnest A, Siow JK, et al. Why generic and disease-specific quality-of life instruments should be used together for the evaluation of patients with persistent allergic rhinitis. Clin Exp Allergy 2005;35(3):288-298 (Pubitemid 40516653)
42. McColl E, Eccles MP, Rousseau NS, Steen IN, Parkin DW, Grimshaw JM. From the generic to the conditionspecific?: Instrument order effects in Quality of Life Assessment. Med Care 2003;41(7):777-790
43. Brommels M, Sintonen H. Be generic and specific: quality of life measurement in clinical studies. Ann Med 2001;33(5):319-322 (Pubitemid 32675371)
44. Mousavi B, Soroush MR, Montazeri A. Quality of life in chemical warfare survivors with ophthalmologic injuries: the first results form Iran Chemical Warfare Victims Health Assessment Study. Health Qual Life Outcomes 2009;7:2.